Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peterfy

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
The Lancet. Rheumatology|January 27, 2024
Non-invasive vagus nerve stimulation for rheumatoid arthritis: a proof-of-concept studySara Marsal, Héctor Corominas, Juan José de Agustín, et al.
Annals of the Rheumatic Diseases|August 9, 2011
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomesJ Bathon, M Robles, A C Ximenes, et al.
The Journal of Rheumatology|February 17, 2015
The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research PrioritiesMikkel Østergaard, Paul Bird, Frédérique Gandjbakhch, et al.
Osteoarthritis and Cartilage|May 9, 2015
OARSI Clinical Trials Recommendations: Hand imaging in clinical trials in osteoarthritisD J Hunter, N Arden, F Cicuttini, et al.
The Journal of Rheumatology|September 3, 2011
Development and preliminary validation of a magnetic resonance imaging joint space narrowing score for use in rheumatoid arthritis: potential adjunct to the OMERACT RA MRI scoring systemMikkel Ostergaard, Pernille Bøyesen, Iris Eshed, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritisMargreet Kloppenburg, Charles Peterfy, Ida K Haugen, et al.
The Oncologist|July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN studyAndrew J Wagner, William D Tap, Sebastian Bauer, et al.
The Journal of Rheumatology|August 13, 2009
The OMERACT MRI inflammatory arthritis group: advances and future research prioritiesPhilip G Conaghan, Paul Bird, Fiona McQueen, et al.
Cancer|November 16, 2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumorsHans Gelderblom, Andrew J Wagner, William D Tap, et al.
Future Oncology (London, England)|January 18, 2022
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burdenCharles Peterfy, Yan Chen, Peter Countryman, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
The Lancet. Rheumatology|January 27, 2024
Non-invasive vagus nerve stimulation for rheumatoid arthritis: a proof-of-concept studySara Marsal, Héctor Corominas, Juan José de Agustín, et al.
Annals of the Rheumatic Diseases|August 9, 2011
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomesJ Bathon, M Robles, A C Ximenes, et al.
The Journal of Rheumatology|February 17, 2015
The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research PrioritiesMikkel Østergaard, Paul Bird, Frédérique Gandjbakhch, et al.
Osteoarthritis and Cartilage|May 9, 2015
OARSI Clinical Trials Recommendations: Hand imaging in clinical trials in osteoarthritisD J Hunter, N Arden, F Cicuttini, et al.
The Journal of Rheumatology|September 3, 2011
Development and preliminary validation of a magnetic resonance imaging joint space narrowing score for use in rheumatoid arthritis: potential adjunct to the OMERACT RA MRI scoring systemMikkel Ostergaard, Pernille Bøyesen, Iris Eshed, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritisMargreet Kloppenburg, Charles Peterfy, Ida K Haugen, et al.
The Oncologist|July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN studyAndrew J Wagner, William D Tap, Sebastian Bauer, et al.
The Journal of Rheumatology|August 13, 2009
The OMERACT MRI inflammatory arthritis group: advances and future research prioritiesPhilip G Conaghan, Paul Bird, Fiona McQueen, et al.
Cancer|November 16, 2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumorsHans Gelderblom, Andrew J Wagner, William D Tap, et al.
Future Oncology (London, England)|January 18, 2022
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burdenCharles Peterfy, Yan Chen, Peter Countryman, et al.
Pageof 19